In BD patients, the levels of atherosclerotic and inflammatory markers, such as tumor necrosis factor-α (TNF-α), lipoprotein-associated phospholipase A2 (Lp-PLA2), and homocysteine, are increased14. This evidence concerns the gene PLA2G7 and Behcet disease.